Skip to main content
Clinical Trials/KCT0007132
KCT0007132
Completed
未知

Effects of Anesthetic agents (propofol vs. remimazolam) on recovery outcomes in patients undergoing arrhythmia catheter ablation: a prospective, randomized, and controlled trial

Samsung Medical Center0 sites100 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Diseases of the circulatory system
Sponsor
Samsung Medical Center
Enrollment
100
Status
Completed
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
August 2, 2022
Last Updated
3 years ago
Study Type
Interventional Study
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • 1\) ASA class I\-IV adult (19\-70 years of age)
  • 2\) Undergoing elective cathter ablation procedure for atrial fibrillation/flutter under general anesthesia

Exclusion Criteria

  • 1\) History of hypersensitivity to benzodiazepines or propofol
  • 2\) Moderate liver disease (Child\-Pugh B/C)
  • 3\) Diagnosed with metabolic disease
  • 4\) Pregnant or breast\-feeding
  • 5\) Acute glaucoma
  • 6\) Galactose intolerance, lactose intolerance, or glucose\-galactose absorption disorder
  • 7\) Severe hypersensitivity to Dextran 40

Outcomes

Primary Outcomes

Not specified

Similar Trials